Don't chase up, don't go short (except for protective shorting), buy a bounce back near the stop-loss point, and stop losing if it falls below. Companies that don't use leverage don't buy it, and companies that haven't learned how to make a profit don't buy it.
Compared to the stock market, I am more optimistic about bonds; my pension is already full of bonds. I set up a flag a month ago. At the time, TLT was 100 yuan and spy was 400 yuan. Let's see if they'll be punched in the face in a year. But bonds are really boring, so I'm still playing with stocks
高贵的阿德莱德
OPEbaox
:
From a fundamental point of view, unless the coronavirus mysteriously disappears, people will still have to take medicine and get vaccinated, and related stocks have reached a point of value depression. But the technical side really makes people cry and laugh. The US fight against the epidemic began to lie flat in December 2021. A number of new variants were born in 2022. The epidemic repeated several waves over and over again, and the biggest backlash was in April 2022. China lay flat in December 2022, and now it's almost April again to see if COVID-19 will make a comeback
勇敢韭韭不怕困难
高贵的阿德莱德
OP
:
As for semiconductors, I don't buy them now, and they aren't empty...It's really embarrassing. I'm bored watching “Chip Wars.” I would still buy back asml and Nvidia at the right price.
高贵的阿德莱德
OPmubbiiee
:
The fundamentals are fine, and the company's moat is also good. The company's profitability is still there, so it won't drop that much. I think it's because of the recent veteran litigation issue. It's been sold off quite a bit. It's already underestimated, but I don't have the funds to dig the bottom
mubbiiee
高贵的阿德莱德
OP
:
Thanks for the explanation. Looking at the data alone, it's a falling stock; it doesn't have much potential for growth. The valuation is slightly underestimated. Compared to 14-15, revenue increased by less than 10%, and the EPS growth was OK. Maybe there will be a repurchase? The debt is slightly high, and I don't know if financing costs will affect future profit margins. If it doesn't continue to fall, it's OK to collect dividends.
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Ebaox : I feel like Pfizer has almost dropped, but now that it's lying down, it's worrying
高贵的阿德莱德 OP Ebaox : From a fundamental point of view, unless the coronavirus mysteriously disappears, people will still have to take medicine and get vaccinated, and related stocks have reached a point of value depression. But the technical side really makes people cry and laugh. The US fight against the epidemic began to lie flat in December 2021. A number of new variants were born in 2022. The epidemic repeated several waves over and over again, and the biggest backlash was in April 2022. China lay flat in December 2022, and now it's almost April again to see if COVID-19 will make a comeback
勇敢韭韭不怕困难 : Pfizer Johnson & Johnson has stopped all of their hearts beating for 3 meters.
高贵的阿德莱德 OP 勇敢韭韭不怕困难 : Maybe all the funds have gone to the bottom of the bank![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
勇敢韭韭不怕困难 高贵的阿德莱德 OP : They've all gone to semiconductors.![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
高贵的阿德莱德 OP 勇敢韭韭不怕困难 : Semiconductors have not been able to rise a bit in the past two days, so I don't know when they will return to reasonable prices.
勇敢韭韭不怕困难 高贵的阿德莱德 OP : As for semiconductors, I don't buy them now, and they aren't empty...
It's really embarrassing. I'm bored watching “Chip Wars.”![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
I would still buy back asml and Nvidia at the right price.
mubbiiee : Can you explain 3m? The fundamentals of this product don't look good; I don't think it's as good as buying Spy.
高贵的阿德莱德 OP mubbiiee : The fundamentals are fine, and the company's moat is also good. The company's profitability is still there, so it won't drop that much. I think it's because of the recent veteran litigation issue. It's been sold off quite a bit. It's already underestimated, but I don't have the funds to dig the bottom
mubbiiee 高贵的阿德莱德 OP : Thanks for the explanation. Looking at the data alone, it's a falling stock; it doesn't have much potential for growth. The valuation is slightly underestimated. Compared to 14-15, revenue increased by less than 10%, and the EPS growth was OK. Maybe there will be a repurchase? The debt is slightly high, and I don't know if financing costs will affect future profit margins. If it doesn't continue to fall, it's OK to collect dividends.
View more comments...